Cargando…
Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can “Thrombin Pathway” Be a New Target for Therapy?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Cardiology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440994/ https://www.ncbi.nlm.nih.gov/pubmed/32812410 http://dx.doi.org/10.4070/kcj.2020.0287 |
| _version_ | 1783573223009419264 |
|---|---|
| author | Kim, Hyun Kuk Tantry, Udaya S. Gurbel, Paul A. Jeong, Young-Hoon |
| author_facet | Kim, Hyun Kuk Tantry, Udaya S. Gurbel, Paul A. Jeong, Young-Hoon |
| author_sort | Kim, Hyun Kuk |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7440994 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | The Korean Society of Cardiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74409942020-09-01 Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can “Thrombin Pathway” Be a New Target for Therapy? Kim, Hyun Kuk Tantry, Udaya S. Gurbel, Paul A. Jeong, Young-Hoon Korean Circ J Editorial The Korean Society of Cardiology 2020-08-03 /pmc/articles/PMC7440994/ /pubmed/32812410 http://dx.doi.org/10.4070/kcj.2020.0287 Text en Copyright © 2020. The Korean Society of Cardiology https://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Kim, Hyun Kuk Tantry, Udaya S. Gurbel, Paul A. Jeong, Young-Hoon Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can “Thrombin Pathway” Be a New Target for Therapy? |
| title | Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can “Thrombin Pathway” Be a New Target for Therapy? |
| title_full | Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can “Thrombin Pathway” Be a New Target for Therapy? |
| title_fullStr | Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can “Thrombin Pathway” Be a New Target for Therapy? |
| title_full_unstemmed | Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can “Thrombin Pathway” Be a New Target for Therapy? |
| title_short | Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can “Thrombin Pathway” Be a New Target for Therapy? |
| title_sort | another unmet need against residual risk of atherosclerotic cardiovascular disease: can “thrombin pathway” be a new target for therapy? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440994/ https://www.ncbi.nlm.nih.gov/pubmed/32812410 http://dx.doi.org/10.4070/kcj.2020.0287 |
| work_keys_str_mv | AT kimhyunkuk anotherunmetneedagainstresidualriskofatheroscleroticcardiovasculardiseasecanthrombinpathwaybeanewtargetfortherapy AT tantryudayas anotherunmetneedagainstresidualriskofatheroscleroticcardiovasculardiseasecanthrombinpathwaybeanewtargetfortherapy AT gurbelpaula anotherunmetneedagainstresidualriskofatheroscleroticcardiovasculardiseasecanthrombinpathwaybeanewtargetfortherapy AT jeongyounghoon anotherunmetneedagainstresidualriskofatheroscleroticcardiovasculardiseasecanthrombinpathwaybeanewtargetfortherapy |